XNAS
THRM
Market cap1.11bUSD
Jul 22, Last price
36.05USD
1D
-1.61%
1Q
21.75%
Jan 2017
6.50%
Name
Gentherm Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Gentherm Incorporated is a company dedicated to the creation, production, and sale of advanced thermal management technologies. Its operations are divided into two principal business segments: Automotive and Medical. The Automotive segment offers an extensive range of climate comfort systems, encompassing active heating and cooling solutions for seats (utilizing heaters, blowers, and thermoelectric devices for precise temperature regulation), heated steering wheels, and specialized thermal comfort products for areas like the neck, door panels, armrests, cupholders, and storage bins. This segment also develops integrated electronic components, including proprietary electronic control units (ECUs) and software essential for these comfort features, as well as general automotive electronic and software systems like memory seat modules. Additionally, Gentherm provides battery performance solutions, which include cell connecting devices, advanced battery cable technologies, and thermal management systems designed to heat and cool 12-volt, 48-volt, and high-voltage automotive batteries and modules. Its clientele in this segment primarily consists of light vehicle original equipment manufacturers (OEMs), key first-tier suppliers (such as automotive seat manufacturers), and aftermarket seat distributors and installers. The Medical segment focuses on delivering systems for managing patient temperature. Gentherm has a wide international footprint, with its products and services available across the United States, Germany, Canada, China, Hungary, Japan, South Korea, Romania, Macedonia, Malta, Mexico, the United Kingdom, Ukraine, and Vietnam. Founded in 1991 as Amerigon Incorporated, the company rebranded to Gentherm Incorporated in September 2012 and is based in Northville, Michigan.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||